Zogenix receives US approval for subcutanous needle-free sumatriptan
This article was originally published in Scrip
Executive Summary
Zogenix's needle-free, single-use, subcutaneous migraine product, Sumavel DosePro (sumatriptan), has been approved for marketing in the US.